Home EndoGastric Solutions

EndoGastric Solutions

New Publication on TIF 2.0 in Therapeutic Advances in Gastroenterology

The article, authored by Glenn Ihde, MD, a board-certified general surgeon at the Matagorda Medical Group in Bay City, Texas, provides an overview of current best practices with respect to TIF 2.0 as a stand-alone procedure as well as in conjunction with hiatal hernia (HH) repair.

EndoGastric Solutions® Announces New Data Demonstrating pH Control Following TIF 2.0 and Hiatal Hernia Repair Procedures in GERD Patients

2/5/19: The TIF 2.0 procedure is a minimally invasive endoscopic intervention performed with the EsophyX® device that enables anatomic correction of the gastroesophageal valve without the resulting complications associated with traditional fundoplication. The retrospective data are reported in a paper titled “pH Scores in Hiatal Repair with Transoral Incisionless Fundoplication,” and appear in the January - March 2019 issue of the Journal of the Society of Laparoendoscopic Surgeons.

EndoGastric Solutions Announces New Data Demonstrating the Feasibility, Safety and Efficacy of EsophyX® Z Device in TIF 2.0 Procedure Following Peroral Endoscopic Myotomy

6/26/18: This study, titled, “Transoral Incisionless Fundoplication for reflux after peroral endoscopic myotomy: a crucial addition to our arsenal” appeared in the May issue of Endoscopy International Open.

EndoGastric® Solutions Announces Expanded Medicare Reimbursement for Transoral Incisionless Fundoplication (TIF®) Procedure

Medicare beneficiaries in 10 Midwestern and Northeastern states will soon have reimbursed access to the Transoral Incisionless...

EndoGastric Solutions® Expands Commercial Leadership Team to Meet Increased Demand for TIF® Procedure for Reflux

EndoGastric Solutions Inc. (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today...

EndoGastric Solutions to Host Product Theater Session on the TIF® Procedure at Digestive Disease Week® (DDW) 2017

EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that...